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cancer were 0.29 (0.24–0.36) for post-ad, 0.81 (0.61–1.07) for 
post-crc, and 2.77 (2.43–3.17) for positive FOBT.  Conclusion: 
Colonoscopy for post-ad surveillance but not colonoscopy 
for post-crc surveillance is associated with a lower risk of di-
agnosis of advanced adenoma and cancer. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Colorectal cancer is among the most frequent causes 
of cancer-related morbidity and mortality  [1, 2] . Screen-
ing of asymptomatic individuals has been recommended 
by national and international guidelines  [3–5] . Colonos-
copy is performed either as the primary screening or for 
the work-up of individuals with positive fecal occult 
blood test (FOBT), sigmoidoscopy, or virtual colonogra-
phy. Cohort studies have demonstrated a reduction of in-
cidence and mortality from colorectal cancer after colo-
noscopic polypectomy  [6, 7] . Surveillance by colonosco-
py is recommended in defined intervals after curative 
resection of colorectal cancer and after endoscopic re-
moval of adenomatous polyps to detect metachronous 
cancer and adenoma  [4, 8, 9] . It has been demonstrated 
that the frequency of metachronous cancer detected upon 
surveillance colonoscopy after resection of colorectal 
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 Abstract 
 Background/Aims: Surveillance colonoscopy is recom-
mended after polypectomy of adenoma and surgery for 
colorectal cancer. The purpose of this study was to assess 
the frequency of advanced adenoma and cancer in colonos-
copies performed for surveillance compared to screening 
colonoscopies.  Methods: Analysis of relative frequencies of 
findings in colonoscopies performed for post-adenoma 
 surveillance (post-ad), post-cancer surveillance (post-crc), 
screening, and follow-up of a positive fecal occult blood test 
(FOBT). Logistic regression was used to identify the risk for 
advanced adenoma (adenoma  ≥ 10 mm, containing high-
grade dysplasia, or villous histology) and cancer.  Results: 
324,912 colonoscopies were included in the analysis: 81,877 
post-ad, 26,896 post-crc, 178,305 screening, 37,834 positive 
FOBT. Advanced adenoma (cancer) was diagnosed in 8.0% 
(0.4%) of post-ad, 5.0% (1.0%) of post-crc, 7.4% (1.1%) of 
screening, and 11.7% (3.6%) of positive FOBT colonoscopies. 
Compared to screening, the odds ratios for finding advanced 
adenoma were 0.93 (95% CI 0.88–0.98) for post-ad, 0.96 
(0.86–1.08) for post-crc, and 1.18 (1.09–1.28) for positive 
FOBT colonoscopies. The odds ratios for the diagnosis of 
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cancer is comparable with the rate of cancers detected 
upon screening colonoscopy  [8] . Studies on the risk of 
metachronous cancer after polypectomy have yielded 
discordant results: some studies have reported an in-
creased risk  [10–14] , others have reported a reduced risk 
 [6, 15–17] .
 So far the frequency and risk of metachronous cancer 
and advanced adenoma upon post-cancer and post-ade-
noma surveillance have not been assessed in the same 
study. To determine the risk of advanced adenoma and 
cancer in surveillance colonoscopies, we analyzed a large 
sample of colonoscopies done for surveillance after cura-
tive resection of colorectal cancer or removal of colonic 
adenomas. We determined the relative frequencies of 
findings and calculated the risk of advanced adenoma and 
cancer in surveillance colonoscopies.
 Material and Methods 
 Colonoscopy Registry 
 The Bavarian Association of Compulsory Health Insurance 
(CHI) Physicians documents all outpatient colonoscopies in a 
central database. Only endoscopists with a documented experi-
ence of   ≥ 200 colonoscopies and  ≥ 50 polypectomies within the 
past 2 years and a continuously high volume of colonoscopies 
and polyp ectomies are certified to perform colonoscopies in out-
patients insured by the CHI system covering about 83% of the 
Bavarian population. Online documentation is required for re-
imbursement. No individual patient identification data are con-
tained in the database and data collection has been approved by 
the Bavarian governmental authority for data protection. For this 
analysis, datasets of all colonoscopies performed in adults for pri-
mary screening, for follow-up on a positive FOBT, for post-can-
cer or post-adenoma surveillance between January 2006 and De-
cember 2008 were available. The findings on colonoscopy were 
categorized on the basis of the most advanced lesion found. Colo-
noscopies done in individuals younger than 18 years, individuals 
with a history of chronic inflammatory bowel disease, individuals 
with increased family risk, and repeat examinations were exclud-
ed from analysis. In case of repeat examinations only the index 
colonoscopy was included. Advanced adenoma was defined as 
adenoma that was at least 10 mm in diameter, had high-grade 
dysplasia, had villous or tubulovillous histologic characteristics, 
or any combination thereof.
 Statistical Analysis 
 Distributions of characteristics of patients, colonoscopies, com-
plications, and detected lesions were described using absolute and 
relative frequencies. Adenoma detection rates were defined as the 
proportions of subjects in whom at least one adenoma was identi-
fied. We modeled the risks of advanced adenoma and cancer in pa-
tients with lesions using logistic regression models including the 
following fixed set of independent variables: lesion count, size of the 
largest lesion, localization of the largest lesion, gender, age, age 
squared, age cubed, and indication for colonoscopy. All analyses 
were performed using SAS version 9.2 for Linux (SAS Institute, Inc., 
Cary, N.C., USA).
 Results 
 For this analysis, a total of 324,912 colonoscopies per-
formed in adults were included ( table 1 ). 158,788 (48.9%) 
individuals were  ≤ 64 years and 166,124 (51.1%) were  ≥ 65 
years, 169,606 (52.2%) were female and 155,306 (47.8%) 
were male. 81,877 (25.2%) colonoscopies were done for 
post-adenoma surveillance, 26,896 (8.3%) colonoscopies 
were done for post-cancer surveillance, 178,305 (54.9%) 
colonoscopies were primary screening studies, and 37,834 
(11.6%) colonoscopies were done for work-up of a posi-
tive FOBT. 299,021 (92.03%) colonoscopies were done 
under sedation ( table  2 ). In 318,182 (97.93%) colono-
Table 1.  Demographic characteristics
Characteristic Individuals, n (%)
Total 324,912 (100.00)
Age group, years
≤64 years 158,788 (48.9)
≥65 years 166,124 (51.1)
Sex
Male 155,306 (47.8)
Female 169,606 (52.2)
Indication for colonoscopy
Primary screening colonoscopy 178,305 (54.9)
FOBT+ work-up colonoscopy 37,834 (11.6)
Post-adenoma surveillance colonoscopy 81,877 (25.2)
Post-cancer surveillance colonoscopy 26,896 (8.3)
Table 2.  Characteristics of colonoscopies
Characteristic Colonoscopies, n (%)
Sedation 299,021 (92.03)
Cecum rate 318,182 (97.93)
Incomplete due to
Remaining stool 795 (0.24)
Stenosis 1,356 (0.42)
Pain 571 (0.18)
Complication 83 (0.03)
Other 3,925 (1.21)
Complication
Bleeding 680 (0.21)
Perforation 88 (0.03)
Cardiopulmonary 126 (0.04)
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scopies the cecum was reached. The colonoscopy was 
 incomplete due to remaining stool in 795 (0.24%), due to 
stenosis in 1,356 (0.42%), due to pain in 571 (0.18%), due 
to complications in 83 (0.03%), and due to other reasons 
in 3,925 (1.21%) of cases. A complication occurred in 
894 (0.28%) colonoscopies: 680 bleedings (0.21%), 88 per-
forations (0.03%), and 126 (0.04%) cardiopulmonary 
complications.
 63,621 (19.58%) of the colonoscopies revealed non-
advanced adenomas, 25,580 (7.78%) revealed advanced 
adenomas, and 3,808 (1.17%) revealed cancers ( table 3 ). 
The adenoma detection rates of all colonoscopies were 
27.5%: 24.9% for screening colonoscopies, 26.3% for 
work-ups for positive FOBT, 35.9% for post-adenoma 
surveillance, and 20.7% for post-cancer surveillance 
( fig. 1 ). Of the 178,305 screening colonoscopies, 31,084 
(17.43%) reported non-advanced adenomas, 13,215 
(7.41%) reported advanced adenomas, and 1,865 (1.05%) 
reported cancers as the most advanced lesion found. 
5,513 (14.57%) of the 37,834 colonoscopies done for fol-
low-up of a positive FOBT identified non-advanced ad-
enomas, 4,432 (11.71%) advanced adenomas, and 1,369 
(3.62%) cancers. 81,877 colonoscopies done for post-
adenoma surveillance revealed 22,815 (27.87%) non-ad-
vanced adenomas, 6,583 (8.04%) advanced adenomas, 
and 297 (0.36%) cancers. The 26,896 colonoscopies per-
formed for post-cancer surveillance identified 4,209 
(15.65%) non-advanced adenomas, 1,350 (5.02%) ad-
vanced adenomas, and 277 (1.03%) cancers.
 Logistic regression was performed to identify the risk 
for cancer and advanced adenoma in surveillance colo-
noscopies ( fig. 2 ). Colonoscopies done for post-adenoma 
surveillance were associated with a lower risk of carrying 
cancer (OR 0.29; 95% CI 0.24–0.36) or advanced adeno-
ma (OR 0.93; 95% CI 0.88–0.98) than screening colonos-
copies. The risk of finding cancer (OR 0.81; 95% CI 0.61–
1.07) or advanced adenoma (OR 0.96; 95% CI 0.86–1.08) 
upon colonoscopy was similar for post-cancer surveil-
lance and screening. Compared to screening colonosco-
pies, FOBT follow-up colonoscopies were associated with 
the highest risk of finding cancer (OR 2.77; 95% CI 2.43–
3.17) or advanced adenoma (OR 1.18; 95% CI 1.09–1.28).
40
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 Fig. 1. Adenoma detection rates. 
Table 3.  Neoplastic lesions found according to indication for colonoscopy
Total
n (%)
Screening 
colonoscopies
n (%)
FOBT+ work-up 
colonoscopies
n (%)
Post-adenoma 
surveillance
n (%)
Post-cancer
surveillance
n (%)
Number of colonoscopies 324,912 (100.00) 178,305 (100.00) 37,834 (100.00) 81,877 (100.00) 26,896 (100.00)
Non-advanced adenoma 63,621 (19.58) 31,084 (17.43) 5,513 (14.57) 22,815 (27.87) 4,209 (15.65)
Advanced adenoma 25,580 (7.87) 13,215 (7.41) 4,432 (11.71) 6,583 (8.04) 1,350 (5.02)
Cancer 3,808 (1.17) 1,865 (1.05) 1,369 (3.62) 297 (0.36) 277 (1.03)
0.2 0.4 0.6 0.8 1
Odds ratio (95% confidence interval)
2 3
Advanced
adenoma
FOBT+
2.77 (2.43–3.17)
0.81 (0.61–1.07)
1.18 (1.09–1.28)
0.96 (0.86–1.08)
0.93 (0.88–0.98)
0.29 (0.24–0.36)
Post-adenoma
Post-cancer
Cancer
FOBT+
Post-adenoma
Post-cancer
 Fig. 2. Odds ratios for the diagnosis of cancer and advanced ade-
noma as compared to primary colonoscopy screening. The dashed 
vertical line represents the odds ratio of screening colonoscopy. 
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 Discussion 
 The present study is based on a large cohort of routine 
surveillance colonoscopies done in unselected individu-
als. The study analyzes the risk of advanced adenoma and 
cancer in post-cancer and post-adenoma surveillance in 
parallel to screening colonoscopies, representing a group 
of individuals at average risk, and colonoscopies done for 
work-up of positive FOBTs, representing a group at in-
creased risk. Colonoscopies done in individuals with a 
known increased family risk for colorectal cancer were 
excluded to avoid a bias due to different basic risks. The 
quality of the colonoscopies documented in the database 
is highly reflected by a low complication rate, a high rate 
of complete examinations, and adenoma detection rates 
above 20%. We demonstrate that colonoscopies done for 
post-adenoma surveillance are associated with a reduced 
risk of advanced adenoma and cancer compared to 
screening colonoscopy. Individuals undergoing post-
cancer surveillance have a similar risk for advanced ade-
noma and cancer as individuals undergoing screening. As 
expected, colonoscopies done for follow-up of a positive 
FOBT, representing a high-risk group, had the highest 
risk for advanced adenoma and cancer.
 An adenoma detection rate of 20% or higher has been 
demonstrated to be associated with the lowest risk of 
interval colorectal cancer after screening colonoscopy 
 [18] . In the same study the cecal intubation rate was not 
significantly associated with this risk. The adenoma 
 detection rate was above 20% in all of the four colon-
oscopy indication groups in our study, demonstrating 
the high quality of the colonoscopists. However, it was 
highest in the post-adenoma surveillance group with 
35.9% and lowest in the post-cancer surveillance group 
with 20.7%. As these colonoscopies have been per-
formed by the same endoscopists there is no reason to 
assume a difference in the quality of the colonoscopies. 
A potential and possibly most likely explanation for the 
lowest adenoma detection rate in the post-cancer 
 surveillance group is the status of partial or hemicolec-
tomy due to the history of cancer resulting in a reduced 
total colonic surface. The high adenoma detection rate 
in the post-adenoma surveillance group is mainly due 
to the high number of non-advanced adenomas  resulting 
in a  non-advanced-to-advanced adenoma ratio of 3.5 
 compared to a ratio of 2.4 in the screening group. An 
even higher adenoma detection rate of 39.7% and a 
 similarly high ratio of 2.9 have previously been reported 
in a cohort of post-adenoma surveillance colonoscopies 
 [14] .
 The rationale for surveillance after polypectomy is 
that size, number and histology of adenoma at baseline 
colonoscopy indicate the risk for the development of 
metachronous cancer and advanced adenoma  [9] . We 
find that colonoscopies performed for post-adenoma 
surveillance are associated with a significantly lower risk 
of finding cancer or advanced adenoma than screening 
colonoscopies. This might indicate a protective effect of 
clearing the colon of adenomas during a prior colonos-
copy. Our frequencies of findings are in line with other 
studies, for example Cottet et al.  [14] reported on 4,881 
colonoscopies done for surveillance after removal of ad-
enoma: 29.6% colonoscopies revealed a non-advanced 
adenoma, 10.1% an advanced adenoma, and 0.1% cancer 
as the most advanced lesion found. The researchers of the 
National Polyp Study reported on 26.6% non-advanced 
adenomas upon the first surveillance colonoscopy and 
20.7% non-advanced adenomas upon the second surveil-
lance colonoscopy  [19] . However, the rates of advanced 
adenoma were 2.9 and 0.9% in this study, respectively. 
This stands in strong contrast to our and Cottet’s find-
ings and is most likely due to the fact that the numbers 
reported by Winawer et al.  [19] are based on a trial while 
our and Cottet’s studies are based on routine colonosco-
pies. Still the high rate of non-advanced adenomas in all 
three studies may be explained by an increased risk for 
developing adenoma after polypectomy supporting the 
surveillance recommendations. Furthermore, due to 
surveillance, these earlier adenomas might not have had 
the time to advance in size and towards more severe his-
tological abnormalities. Another issue that needs to be 
discussed in this context is that colonoscopy misses a 
substantial number of small lesions as has been demon-
strated by back-to-back colonoscopy studies  [20] . There-
fore, it cannot be excluded that the high number of non-
advanced adenomas in the surveillance groups is at least 
in part due to failure of colonoscopy to detect and remove 
these lesions at baseline colonoscopy. We find a strongly 
reduced risk of cancer in the post-adenoma surveillance 
group compared to the screening group which can be as-
sumed to be at average risk. Cottet et al.  [14] reported on 
an increased risk of colorectal cancer after polypectomy 
compared to the expected number of cases. However, a 
significant difference was only seen in the group of indi-
viduals with advanced adenoma at baseline colonoscopy 
who did not have surveillance colonoscopy but not in the 
group that received surveillance colonoscopies. This 
group was shown to be at similar risk as the general pop-
ulation. Several other studies have also reported on the 
cancer risk after removal of adenoma. Studies reporting 
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on cohorts of populations without surveillance have re-
ported on an increased risk  [10–13] while a reduced risk 
has been reported in studies with systematic surveillance 
after polypectomy  [6, 15–17] . Therefore, polypectomy 
in combination with surveillance colonoscopy and not 
polypectomy alone appears to reduce the risk of colorec-
tal cancer.
 Surveillance colonoscopy in patients after resection of 
colorectal cancer intends to detect early recurrences of the 
resected cancers and to detect metachronous cancers  [20] . 
Anastomotic recurrences have been demonstrated to be 
less frequent in colon than in rectal cancer patients. It has 
been shown that the risk of a second colorectal cancer re-
mains high after curative resection of colorectal cancer 
 [21] . A meta-analysis has found that the rate of metachro-
nous cancers detected upon surveillance compares very 
well with the rate of prevalent cancers detected during 
screening colonoscopy  [20] . However, some of the cancers 
detected, especially those detected early after resection, 
may represent synchronous lesions missed at the time of 
the initial diagnosis. There are at least three potential rea-
sons for the higher cancer rate in the post-cancer than in 
the post-adenoma surveillance group: (1) compliance 
with surveillance recommendations may have differed be-
tween groups; (2) patients with a history of cancer may 
differ biologically from patients with adenomatous polyps 
and may therefore have a higher risk, and (3) clearing of 
the colon from adenoma may not have been as rigorous in 
the initial colonoscopy in the cancer as in the adenoma 
group. Our study does not give the answer, however it re-
confirms the necessity for surveillance after surgery for 
colorectal cancer. Future studies need to clarify this di-
lemma and how to further reduce the risk of metachro-
nous cancer.
 Three major issues related to the database underlying 
this analysis limit the conclusions that may be drawn 
from this study. First, we do not know the time interval 
since resection of the cancer or removal of the adenoma 
and surveillance colonoscopy. Furthermore, we do not 
know whether the surveillance colonoscopy documented 
in the database was the first or a repeat examination after 
resection of the cancer or removal of the adenoma. The 
risk of advanced adenoma and cancer may be different in 
a first compared to a repeat surveillance colonoscopy. 
Therefore, our study is only able to give mean numbers 
for first and repeat surveillance colonoscopies. Future da-
tabase documentation should account for this. Second, 
our study is a retrolective analysis of routine data not pri-
marily collected for scientific purposes, such as the analy-
sis of risk for advanced adenoma and cancer in surveil-
lance colonoscopies. A negative consequence of this is 
that we neither know the stage of the original tumor in 
the post-cancer surveillance group, nor the size, number 
and histology of adenomas removed in the post-adenoma 
surveillance group. As size, histology, and multiplicity of 
the polyps removed at baseline colonoscopy predict the 
subsequent detection of advanced adenomas  [9] , this 
would have been important information. Accordingly, 
guidelines recommend surveillance colonoscopy 3 years 
after removal of advanced adenomas and 5 years after re-
moval of non-advanced adenomas. Moreover, patients 
with 3 or more adenomas of any size are also assumed at 
increased risk of advanced adenomas and therefore rec-
ommended surveillance colonoscopy after 3 years  [9] . 
This limitation can best be overcome by prospective stud-
ies. Documentation of this information in the database 
would improve future analyses. Third, another limitation 
is that histology was performed by local pathologists and 
not subject to central review. Systematic over- or under-
reading of advanced histology could introduce bias. How-
ever, in another study employing central pathology re-
view of local pathology interpretation, a systematic bias 
was not detected  [22] .
 In conclusion, this study demonstrates that the risk of 
advanced adenoma and cancer remains at the same level 
after resection of cancer as in an average risk population 
undergoing screening colonoscopy. This reinforces the 
importance of regular surveillance in this subgroup of pa-
tients. Furthermore, the risk of advanced adenoma is 
slightly and the risk of cancer is strongly reduced in indi-
viduals after prior removal of colorectal adenoma. The 
strong reduction of risk for colorectal cancer lends fur-
ther support to the efficacy of colonoscopy in combina-
tion with polypectomy in preventing colorectal cancer. 
As the risk for advanced adenoma is only slightly reduced 
in this subgroup of patients and advanced adenomas bear 
a high potential of malignant transformation, surveil-
lance colonoscopies also need to be done regularly in this 
subgroup.
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